| Trial name or title | Varenicline in residential treatment (ViRT) |
| Methods | Phase IV randomised triple‐blind controlled trial |
| Participants | 50 smokers undergoing inpatient treatment for alcohol dependence |
| Interventions | Varenicline 1 mg x 2/day for 12 weeks vs placebo |
| Outcomes | Abstinence at end of treatment and 30‐day CAR at 6m |
| Starting date | June 2011 |
| Contact information | Laurie Zawertailo |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.